Sanner Previews CPHI Frankfurt Portfolio of CDMO Services, Packaging Innovations

Silica gel granules | Image Credit: © Coprid - stock.adobe.com

Sanner, a provider of customized solutions for medical devices, diagnostics, pharmaceuticals, and consumer healthcare based in Germany, is lining up the equipment and expertise the company plans to display at CPHI Frankfurt, which will be held Oct. 28–30, 2025 (1–3).

In a press release, Sanner said that in the last two years, it has significantly expanded its contract development and manufacturing organization (CDMO) services, particularly in the areas of complex drug delivery and medical device solutions, establishing new manufacturing sites and acquiring two industry-leading design centers of excellence (1).

Who is Sanner’s new CEO, and what’s his background?

“Sanner occupies an important market position in healthcare packaging globally,” Sanner Group CEO Stefan Verheyden, who will attend CPHI as the first trade show in his new role, said in the press release (1). “With our expanded capabilities and a clear vision, we are ready to solidify a leading position in the MedTech CDMO space.”

Verheyden was announced as the next CEO of Sanner in August 2025 (4). In his previous capacity as global vice-president, Sales, Pharma & Biopharma Solutions—Injectables at Gerresheimer, Verheyden spoke to Pharmaceutical Technology® as part of its Pharmapack Europe coverage in January 2025 about packaging trends for the year ahead.

At that time, Verheyden saw movement toward more at-home therapies and personalized medicine, saying autoinjectors and other drug delivery devices would need to be prioritized to accommodate this trend (5). View the full interview at this link.

What else will Sanner showcase at the conference?

Aside from offering its experts’ knowledge in the finer points of CDMO partnerships, Sanner said it will present its pharmaceutical packaging portfolio at CPHI Frankfurt, including an improved packaging solution for oral solid dosage products that was design-optimized with tailored dessicant solutions, identifying the most proper dessicants even for active ingredients that are highly sensitive (1).

According to Sanner, this approach helps to ensure faster product launches through predictive stability modeling and achievement of stability targets.

“Together with our talented teams and strategic partners, we are committed to shaping the future of our packaging and MedTech business,” Verheyden said (1). “We will continue to invest in advanced technologies, global infrastructure, and customer-centric innovation to deliver exceptional value to our clients and stakeholders.”

How are preparations going for CPHI Europe 2025?

CPHI Frankfurt is expected to welcome more than 63,000 professionals from the bio/pharmaceutical industry as the conference celebrates its 36th year; CPHI Milan drew more than 59,000 attendees in the fall of 2024 (2,3).

For 2025, the three-day event will feature six content theatres and more than 2000 exhibitors, including expanded zones that event organizer Informa Markets said reflect recent diversification in the industry: bioproduction, finished dosage formulation, drug delivery, and packaging, in addition to a traditional focus on APIs (2,3).

Bookmark this page to access all of Pharmaceutical Technology®’s continuing coverage of CPHI Europe in 2025. Sanner will be located at Booth 0J92, in Hall 8 (1).

References

1. Sanner. Sanner at CPHI: Combining CDMO Excellence and Moisture Management Expertise. Press Release. Sept. 17, 2025.
2. Lavery, P. CPHI Frankfurt Expected to Draw More Than 60,000 Attendees in October. PharmTech.com, Sept. 12, 2025.
3. Informa Markets. CPHI Frankfurt 2025 to Welcome More Than 60,000 Pharma Professionals as the Global Event Returns to Germany. Press Release. Sept. 5, 2025.
4. Sanner. Sanner Strengthens Its Position as CDMO—Important Management Change. Press Release. Aug. 8, 2025.
5. Haigney, S. Pharmapack Europe 2025: Packaging Trends. PharmTech.com, Jan. 22, 2025.